Angiocrine factor support by engineered endothelial cells

Engineered endothelial cells, when transplanted into tissues, can recapitulate the supportive paracrine activity of native organ-specific blood vessel endothelium by secreting a diverse set of angiocrine factors—including growth factors, cytokines, chemokines, extracellular matrix components, and exosomes—that promote tissue-specific stem or progenitor cell survival, differentiation, and regeneration[1][2][3][5]. This function is critical not only for maintaining healthy organ homeostasis, but also for orchestrating effective repair after injury and for preventing maladaptive fibrosis. The term "angiocrine factor support" thus refers not to a discrete molecular entity but rather to a coordinated, context-specific program by which endothelial cells influence tissue regeneration and stem cell function through paracrine and juxtacrine signaling. Approaches using engineered endothelial cells aim to recreate or augment these niche signals in therapeutic applications, although the specific molecules involved can vary widely by organ and injury context. In summary, "Angiocrine factor support by engineered endothelial cells" is not a valid therapeutic target or single molecule/receptor; rather, it refers to a complex, multi-factorial regenerative activity mediated by engineered endothelium, and should not be used as a canonical target name for structured molecular databases[1][2][3][5].

Other names

Angiocrine supportAngiocrine factor secretionEndothelial-derived paracrine supportEndothelial niche support